NEW CASE STUDY Unlocking the power of process analytical technology to boost downstream operations    Dive in today!
Contact Us
Contact Us

Press Releases

Find the latest news on AGC Biologics partnerships, product approvals, site expansions, leadership updates, new programs, and more.

Autolus and AGC Biologics

2 min read

AGC Biologics to Manufacture LVV for CAR-T Therapy Approved by FDA for Autolus Therapeutics’ AUCATZYL®

December 11, 2024 at 9:00 AM
Cell & Gene Therapy Press Release
Read press release

2 min read

AGC Biologics Appoints Alberto Santagostino as new Chief Executive Officer

October 28, 2024 at 3:00 AM
Press Release Business Updates
Read press release
Seattle BLAs - 3 approvals in 2024

1 min read

AGC Biologics Seattle Achieves Approval for all 2024 Biologics License Applications from U.S. Food and Drug Administration, Concluding Pre-License Inspection

October 17, 2024 at 3:00 AM
Mammalian & mAbs Press Release Business Updates Microbial
Read press release
AGC Biologics Begins Operations at New State-of-the-Art Manufacturing Building in Copenhagen after Successful Inspection and Licensing from Danish Medicines Agency

1 min read

AGC Biologics Begins Operations at New State-of-the-Art Manufacturing Building in Copenhagen after Successful Inspection and Licensing from Danish Medicines Agency

October 9, 2024 at 11:00 PM
Mammalian & mAbs Press Release Business Updates
Read press release
CompleCure and AGC Biologics Chiba Project Announcement

2 min read

CompleCure Partners with AGC Biologics’ Chiba Site to Develop Advanced Anti-Cancer Therapeutic Using Pioneering AMDC Technology

September 23, 2024 at 4:45 AM
Press Release Process Development Microbial
Read press release

1 min read

AGC and MEDINET Strategic Partnership to Accelerate CGT CDMO Business in Japan

September 16, 2024 at 5:04 PM
Cell & Gene Therapy Press Release
Read press release
AGC Biologics FDA Commercial Approval Copenhagen

2 min read

AGC Biologics Strengthens Portfolio with Latest FDA Commercial Approval at Company’s Copenhagen Facility

August 27, 2024 at 11:05 AM
Mammalian & mAbs Press Release Business Updates
Read press release
NEC Bio Therapeutics and AGC Biologics Announce Collaboration to Manufacture Personalized Cancer Vaccines

2 min read

NEC Bio Therapeutics and AGC Biologics Announce Collaboration to Manufacture Personalized Cancer Vaccines

August 7, 2024 at 7:02 PM
Press Release Business Updates Microbial
Read press release
AGC Biologics' Seattle Headquarters

1 min read

AGC Biologics’ Seattle Site Achieves Successful Multi-Product Inspection by U.S. Food and Drug Administration for Biologics License Applications

July 29, 2024 at 6:30 AM
Mammalian & mAbs Press Release Business Updates
Read press release

2 min read

Essential Pharma and AGC Biologics Partner on late-phase clinical manufacturing of immunotherapy candidate for the treatment of high-risk neuroblastoma

June 17, 2024 at 12:00 AM
Mammalian & mAbs Press Release Business Updates
Read press release
Prev 1 2 3 4 5 Next